Vanda Pharmaceuticals | VNDA - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Eli Lilly USD 9.46B 3.54B 2026-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -80.97M 93.7M 2026-09
J&J USD 8.99B 721M 2026-06
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
Merck USD 1.42B 2.97B 2026-06
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -687M 571M 2026-06
Novartis USD 5.36B 45M 2026-09
Pfizer USD 6.36B 350M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 5.79B 2.1B 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Teva Pharmaceutical Industries USD 1.5B 1.02B 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Veracyte USD 41.24M 2.72M 2026-09